These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9314094)

  • 41. Right Dose, Right Now: Customized Drug Dosing in the Critically Ill.
    Roberts JA; Kumar A; Lipman J
    Crit Care Med; 2017 Feb; 45(2):331-336. PubMed ID: 28098629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
    Roberts JA; Lipman J; Blot S; Rello J
    Curr Opin Crit Care; 2008 Aug; 14(4):390-6. PubMed ID: 18614901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analgesia and sedation in the critically ill--a practical approach.
    Piccolo R; Lipman J; Hon H; Burrows RC
    S Afr J Surg; 1999 Feb; 37(1):15-20. PubMed ID: 10222804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is new in the use of aminoglycosides in critically ill patients?
    Matthaiou DK; De Waele J; Dimopoulos G
    Intensive Care Med; 2014 Oct; 40(10):1553-5. PubMed ID: 24993463
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of aminoglycosides in Danish intensive care units].
    Thorvaldsen M; Christrup LL; Bonde J
    Ugeskr Laeger; 2004 May; 166(23):2246-50. PubMed ID: 15487522
    [No Abstract]   [Full Text] [Related]  

  • 49. [Aminoglycosides to critically ill patients].
    Heslet L; Tvede M; Schierbeck J
    Ugeskr Laeger; 2004 Oct; 166(42):3733. PubMed ID: 15508300
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simpler approaches to aminoglycoside monitoring.
    Matthews SJ; Chow MS
    Am J Hosp Pharm; 1994 Nov; 51(22):2847-8. PubMed ID: 7856616
    [No Abstract]   [Full Text] [Related]  

  • 52. [Simplified handling of aminoglycosides. Daily dosage established on basis of serum creatinine levels].
    Cronberg S
    Lakartidningen; 1993 Oct; 90(40):3421-2, 3427. PubMed ID: 8231484
    [No Abstract]   [Full Text] [Related]  

  • 53. Once daily aminoglycoside dosing in full term neonates.
    Skopnik H; Heimann G
    Pediatr Infect Dis J; 1995 Jan; 14(1):71-2. PubMed ID: 7715998
    [No Abstract]   [Full Text] [Related]  

  • 54. Introduction: infectious diseases in the critically ill.
    Olsen KM; Ng TM
    J Pharm Pract; 2010 Feb; 23(1):5. PubMed ID: 21507787
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of aminoglucosides in critical patients].
    Rello J; Triginer C
    Med Clin (Barc); 1992 Mar; 98(9):355-6. PubMed ID: 1583966
    [No Abstract]   [Full Text] [Related]  

  • 56. Personalized antibiotic dosing for the critically ill.
    Roberts JA; Roger C; De Waele JJ
    Intensive Care Med; 2019 May; 45(5):715-718. PubMed ID: 30637444
    [No Abstract]   [Full Text] [Related]  

  • 57. An emotional-based medicine approach to monitoring once-daily aminoglycosides.
    McCormack JP
    Pharmacotherapy; 2000 Dec; 20(12):1524-7. PubMed ID: 11130226
    [No Abstract]   [Full Text] [Related]  

  • 58. Optimal dosing of aminoglycosides using computerised models.
    Schobben F
    Br J Clin Pract Suppl; 1988 Feb; 57():54-7. PubMed ID: 3140878
    [No Abstract]   [Full Text] [Related]  

  • 59. Comment: aminoglycoside dosing considerations.
    Polk RE
    Ann Pharmacother; 1993; 27(7-8):982-3. PubMed ID: 8364295
    [No Abstract]   [Full Text] [Related]  

  • 60. Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?
    Shahrami B; Arabzadeh AA; Najmeddin F; Sefidani Forough A; Najafi A; Rouini MR; Mojtahedzadeh M
    Am J Ther; 2022 May-Jun 01; 29(3):e376-e378. PubMed ID: 35533328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.